|
|
| Name |
Buckley, Rebecca H. |
| Location
|
Duke University Medical Center |
| Primary Field
|
Immunology and Inflammation |
| Secondary Field
|
Medical Genetics, Hematology and Oncology |
 Election Citation
|
|
Buckley is the leading U.S. figure in the field of primary immunodeficiency diseases. She developed the current highly successful treatment of formerly universally fatal severe combined immunodeficiency diseases (SCIDs) using haploidentical bone marrow transplantation during the neonatal period. |
|
Research Interests
|
|
Dr. Buckley's research interests have been in the fundamental causes of genetically-determined immunodeficiency diseases. For the past 39 years her research has been on the syndrome of severe combined immunodeficiency (SCID) and the longterm clinical and immunologic outcomes of nonablative T cell-depleted haploidentical parental bone marrow transplants. This treatment can be provided to all SCID infants, regardless of whether or not they have a matched sibling donor. For the past two decades she has advocated newborn screening for SCID, and the Secretary of HHS officially recommended that this be implemented in May of 2010. The North Carolina legislature and Governor approved this in 2015. Dr. Buckley is the author or co-author of 375 scientific publications. |
|
|
|